Can Campaign Finance Reform and Stricter Revolving-Door Laws Weaken Pharmaceutical Lobbying Power?
Pharmaceutical lobbying in the United States is among the most powerful forces shaping public health policy. Industry groups spend hundreds of millions of dollars annually on lobbying, campaign contributions, and issue advocacy, making “Big Pharma” consistently one of the highest-spending sectors in Washington. The twin pillars of its political influence are (1) financial...
0 Comments 0 Shares 817 Views 0 Reviews
Sponsored
Sponsored
Sponsored
google-site-verification: google037b30823fc02426.html